A co-culture of fluorescently labeled SW480 tumor cells and CD8+ donor-derived CD8+ T cells was then treated with elraglusib and the percentage of dead cells out of total cells was quantified after 24 h (Supplementary Figure S1D). This evidence concerns the gene CD8A and neoplasm.